Latest Conference Articles

The results of 2 studies likely to have a significant impact upon the treatment of women with metastatic breast cancer.

Dr. Smith on the Brachytherapy Breast Cancer Trial

December 7th 2011, 4:11pm

Dr. Benjamin Smith from MD Anderson Cancer Center Discusses the Brachytherapy Breast Cancer Trial

New Test Predicts Recurrence Risk in Patients With Ductal Carcinoma in Situ

December 7th 2011, 2:14pm

A new 12-gene assay for predicting risk of recurrence for patients with ductal carcinoma in situ (DCIS).

Dr. Solin Discusses the DCIS Score Recurrence Test

December 7th 2011, 12:31pm

Dr. Lawrence Solin from Einstein Medical Center Discusses the DCIS Score Recurrence Test

Gene Signature Identifies Early Versus Late Versus No Recurrence in Hormone Receptor-Positive Breast Cancer

December 7th 2011, 11:27am

It may be possible to predict which women with HR+ invasive breast cancer will experience recurrence by using a series of gene expression profiles.

The 2011 European Multidisciplinary Cancer Congress Slideshow

September 27th 2011, 10:03am

Pictures from The 2011 European Multidisciplinary Cancer Congress (EMCC) in Stockholm, Sweden

Synchronous Radiotherapy With Chemotherapy Improves Local Control in Early Breast Cancer Patients

September 26th 2011, 10:26am

Radiotherapy can be given between or during chemotherapy cycles, rather than sequentially, for women with early breast cancer.

Aflibercept Improves Survival in Metastatic Colorectal Cancer Patients

September 26th 2011, 8:41am

Aflibercept added to FOLFIRI chemotherapy improved PFS and OS in previously treated patients with metastatic colorectal cancer.

T-DM1 Achieves Longer Progression-Free Survival vs. Standard Therapy in HER2+ Metastatic Breast Cancer

September 25th 2011, 5:42am

T-DM1 extended progression-free survival by 40% in HER2+ metastatic breast cancer and was less toxic, compared with standard therapy.

Panitumumab Extends Progression-Free Survival in HPV-Negative Subset of Advanced Head and Neck Cancer

September 25th 2011, 5:05am

Panitumumab + chemo improves OS and PFS in patients with metastatic carcinoma of the head and neck that were negative for HPV.

Survival Benefit Shown With Investigational Alpha-Emitting Radiopharmaceutical in Men With Hormone Resistant Metastatic Prostate Cancer

September 24th 2011, 4:27pm

Investigational drug that emits alpha radiation shows significant improvement in overall survival.

Novel Infusion Approach Significantly Delays Progression in Uveal Melanoma Patients With Liver Metastases

September 24th 2011, 3:35pm

Patients with liver metastases from uveal melanoma had improved survival after treatment with percutaneous hepatic perfusion (PHP).

Two Predictors of Prostate Cancer Explored in Healthy Men

September 23rd 2011, 9:43am

Two studies enhance understanding of risk factors for prostate cancer.

Image of Stockholm City Hall

September 23rd 2011, 7:24am

The 16th ECCO, 36th ESMO, 30th ESTRO Congresses from the 2011 European Multidisciplinary Cancer Congress in Stockholm, Sweden, September 23-27.

ASCO 2011 Annual Meeting Daily Picture Slideshows

June 8th 2011, 4:43pm

American Society of Clinical Oncology (ASCO) 2011 Annual Meeting Daily Picture Slideshow

Updated Cabozantinib Data Includes 6 Patient Deaths

June 7th 2011, 12:06pm

Cabozantinib (XL184), a novel tyrosine kinase inhibitor, caused the deaths of 6 patients in a phase II clinical trial.

Dr. Vogelzang on Mortalities in the Cabozantinib Trial

June 7th 2011, 11:34am

Dr. Vogelzang from the Comprehensive Cancer Centers of Nevada discusses mortalities in cabozantinib trial.

Post-Oophorectomy Hormone Replacement Therapy Safe for BRCA1/2 Mutation Carriers

June 7th 2011, 9:42am

Women who present with BRCA1 and BRCA2 mutation face an increased risk of breast and ovarian cancer.

Dr. Infante Talks About BRAF Mutation Testing

June 7th 2011, 9:22am

Dr. Infante from Sarah Cannon Research Institute Talks About BRAF Mutation Testing

PTEN Expression Does Not Diminish Trastuzumab Effectiveness

June 7th 2011, 8:08am